The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Eisai
Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for HER2+ locally recurrent or metastatic breast cancer (MBC): Results from a phase 2, single-arm, multicenter study.
 
Joyce O'Shaughnessy
Consulting or Advisory Role - Eisai
 
Shannon Leigh Huggins-Puhalla
Consulting or Advisory Role - Celldex; MedImmune; Pfizer
 
Sharon Wilks
No Relationships to Disclose
 
Adam Brufsky
Consulting or Advisory Role - Eisai; Roche
 
Lee Steven Schwartzberg
Leadership - ACORN Research
Consulting or Advisory Role - Amgen; Eisai; Teva
Speakers' Bureau - Eisai; Genentech; Novartis
Research Funding - Eisai
 
Erhan Berrak
Employment - Eisai
 
James X. Song
No Relationships to Disclose
 
David Cox
Employment - Eisai
 
Linda T. Vahdat
Consulting or Advisory Role - Eisai
Speakers' Bureau - Eisai